Home › NCT06292169
Pectoralis Minor Release Versus Non-release in RSA
A Randomized Control Trial to Evaluate Release Versus Non-release of Pectoralis Minor With Reverse Shoulder Arthroplasty
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * All patients undergoing surgery for reverse total shoulder arthroplasty * Patients willing and able to provide informed consent Exclusion Criteria: * Revision arthroplasty * Reverse shoulder arthroplasty for proximal humerus fractures * Adults unable to consent * Individuals who are not yet adults (infants, children, teenagers) * Pregnant women * Prisoners
About the study
The goal of this clinical trial is to assess if concomitant open pectoralis minor release would improve pain and outcomes after Reverse Shoulder Arthroplasty (RSA). The main questions it aims to answer are:
* whether releasing the pectoralis minor prophylactically could have better pain relief * whether releasing the pectoralis minor prophylactically could have increased Range of motion (ROM) outcomes * whether releasing the pectoralis minor prophylactically could have higher final Patient Reported Outcome Measurements (PROMs) Participants will be randomized to either undergo RSA with pectoralis minor release or RSA without pectoralis minor release.
What is being tested
- Pectoralis Minor Release (procedure)
- RSA (procedure)
Sponsor: Emory University · Participants: 90 · Started: Aug 7, 2024
Contact the study team
- Eric Wagner, MD · Phone: 404-778-7249
- Musab Gulzar · Phone: 201-344-0298
Official record on ClinicalTrials.gov — NCT06292169
Locations in the U.S.
| Georgia | Emory Clinic, Atlanta Emory Healthcare Orthopaedics and Spine Center, Atlanta |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.